The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

"Chronic hepatitis delta is the most aggressive form of viral hepatitis and the lack of approved treatments in the United ...

A new study conducted during the first-ever reactive use of the Hecolin vaccine in South Sudan showed that a two-dose regimen ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

Chennai: Deaths due to viral hepatitis, which causes inflammation and damage to the liver, surpassed AIDS, tuberculosis, and malaria nearly a decade a.

Egypt's Minister of Health and Population Khaled Abdel Ghaffar announced that the country has met the regional target for ...